Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cancer Stem Cell Vaccine in Hepatocellular Carcinoma
NCT02089919Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 2, randomised trial in hepatocellular carcinoma (HCC) (4 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Number of participants with adverse events at 3 months. Started Feb 2014; status: completed.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02089919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089919.